Camurus to present at Jefferies 2018 London Healthcare Conference
Lund, Sweden — 10 October 2018 — Camurus (Nasdaq Stockholm; CAMX) today announced that that the Company will present at the Jefferies 2018 London Healthcare Conference 14 November at 4:40 pm local time (GMT). Fredrik Tiberg, President and CEO, will update on the progress of the development pipeline, including the launch preparations for Buvidal® (CAM2038) in Europe, Australia and the US. A webcast of the presentation can be accessed via wsw.com/webcast/jeff115/camx/ . About CamurusCamurus is a Swedish research-based pharmaceutical company